Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Chronicled

Explore full profile

Chronicled is a technology company leveraging blockchain and IoT to power smart, secure supply chain solutions

San Francisco, United StatesFounded 2014Biotech & Life Sciences
Valuation $25–50M Last recorded · 2022
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Chronicled and the history behind them.

About Chronicled

Chronicled, founded in 2012, operates in the blockchain technology sector, focusing on supply chain management. The company leverages blockchain to enhance transparency, security, and efficiency in supply chains, particularly in the pharmaceutical industry. By using blockchain, Chronicled ensures that every transaction and movement of goods is recorded in a tamper-proof ledger, which helps in verifying the authenticity and provenance (origin) of products.

Chronicled primarily serves businesses that deal with physical goods, such as pharmaceutical companies, which require stringent tracking and verification of their products. The company collaborates with these clients to integrate blockchain solutions into their existing systems, ensuring seamless and secure operations.

The market Chronicled operates in is the intersection of blockchain technology and supply chain management. This market is growing as more industries recognize the benefits of blockchain for tracking and verifying the movement of goods. Chronicled's business model revolves around providing blockchain-based solutions and services to its clients. This includes software development, system integration, and ongoing support to ensure the smooth operation of the blockchain networks.

Chronicled generates revenue through a combination of service fees, subscription models, and possibly transaction fees for the use of their blockchain networks. By offering a comprehensive suite of services, Chronicled ensures a steady stream of income while providing significant value to its clients.

In summary, Chronicled is a blockchain technology company that enhances supply chain management for businesses dealing with physical goods, particularly in the pharmaceutical sector. It operates by integrating blockchain solutions into existing systems, ensuring transparency and security. The company makes money through service fees, subscriptions, and transaction fees.

Source: Dealroom company data

At a glance

Founded
2014
Headquarters
San Francisco, United States
Sector
Biotech & Life Sciences

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

Series A9 investors entered at this stage

  • Colbeck Capital Management
  • Solon Mack Capital
  • Pantera Capital
  • Seattle Seahawks
  • Joyance Partners
  • Thursday Ventures
  • The Perkins Fund
  • R/GA Ventures
  • True Global Ventures
Team profiled 26 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States83.3%
🇵🇹 Portugal5.6%
🇧🇷 Brazil5.6%
🇨🇦 Canada5.6%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Chronicled on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Chronicled on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.